Provider Profile:
Salman Fateh, D.O.

School

• New York College of Osteopathic Medicine - 2004

Residency

• Penn State University Hospital - Internal Medicine - 2007

Fellowships

• Penn State University Hospital - Hematology/Oncology - 2010

Awards

• Honors - Internal Medicine Hepatology Senior
• Hershey Medical Center Top 100 July 2011 Smartest Oncologist in America Graduated Magna Cum Laude
• Deans List all four years at Stony Brook University
• Golden Key Honors Certificate of Hematology Oncology Dedication, Hershey Medical Center

Professional Memberships

• Associate Membership American Society Clinical Oncology
• Associate Membership American Society Hematology
• Site Principal Investigator Southwest Oncology Group
• Site Principal Investigator National Surgical Adjuvant Breast and Bowel Project

• Fateh, S., et al. Hematology Oncology Grand Rounds - Apoptosis and Autophagy CPOG ASCO Review iSBTc 24th Annual Meeting "High Dose IL-2 folowed by Temozolmide Results in Response Rates of High Quality in Metastatic Melanoma", Presentation date 09/09
• Risvi, S., Fateh, S., Jiang, Y., "Leptomeningeal Carcinomatosis as the Only Manifestation in Recurrent Gastroesophageal Cancers" Gastrointestinal Cancer Research volume 4, issue 2, pg. 68-71
• Fateh, S., "Ability of unsuccessful high-dose IL-2 therapy followed immediately by low-dose metronomic temozolomide to induce complete and near-complete remissions in metastatic melanoma, 2010 ASCO Annual Meeting Abstract No. e19001
• Site Principal Investigator National Surgical Adjuvant Breast and Bowel Project